After MITF was revealed as a new candidate, we performed reporter, Western blot, and immunofluorescence assays to investigate the functional consequences of the identified variants, using melanoma (G361) and mouse embryonic fibroblast (NIH/3T3) cells. The gene discussed is MITF; the disease is melanoma.